NCT06624150

Brief Summary

This study looks at adults with restrictive eating disorders who are currently receiving outpatient treatment for their eating disorder to examine whether a new brain stimulation technique called non-invasive transcranial direct current stimulation (tDCS) can enhance brain training. Participation involves interviews, assessments, 10 sessions of brain stimulation (active or sham), and computerized brain training over a 3-4 week period, with one post-intervention visit, and one 1-month follow-up visit.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
2mo left

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Aug 2024Jun 2026

First Submitted

Initial submission to the registry

July 19, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

August 2, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 2, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2026

Last Updated

August 29, 2025

Status Verified

August 1, 2025

Enrollment Period

1.8 years

First QC Date

July 19, 2024

Last Update Submit

August 28, 2025

Conditions

Keywords

anorexia nervosaeating disorderbrain trainingbrain stimulationfMRI

Outcome Measures

Primary Outcomes (4)

  • the rate of dropout.

    Feasibility and tolerability measure 1. Evaluating for less than 20% dropout over the course of the tDCS for R-EDs study.

    14 days average

  • Number of participants retained in the tDCS

    Feasibility and tolerability measure 2 . # of participants retained in the tDCS and cognitive training space of the study (80% or more retention will be used as the assessment threshold).

    14 days average

  • probabilistic reversal learning task

    Change from pre intervention to post intervention scores in probabilistic reversal learning task performance

    14 days average

  • Dimensional set shifting task

    change from pre to post intervention scores in dimensional set shifting task.

    14 days average

Study Arms (2)

Active tDCS

EXPERIMENTAL

10 Active tDCS sessions: 10 active sessions of transcranial direct current stimulation paired with cognitive training tasks. Device used is StarStim.

Device: Active tDCS sessions, StarStim device

Sham (fake) tDCS

SHAM COMPARATOR

10 Sham (fake) tDCS sessions: 10 fake sessions of transcranial direct current stimulation paired with cognitive training tasks. The device will be on the participants head, but the current will not be active.

Device: Sham (fake) tDCS sessions

Interventions

10 active sessions of transcranial direct current stimulation paired with cognitive training tasks. Device used is StarStim.

Active tDCS

10 fake sessions of transcranial direct current stimulation paired with cognitive training tasks. The device will be on the participants head, but the current will not be active.

Sham (fake) tDCS

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years
  • Self-reported enrollment in outpatient-level treatment at local eating disorder treatment centers in the Twin Cities region, and meeting DSM-5 criteria for AN (mild severity, based on BMI greater than or equal to 17.0 kg/m2) or atypical AN diagnosis (based on MINI and EDE assessments).
  • Participant must be capable of giving informed consent, based on UCSD Brief Assessment of Capacity to Consent (UBACC) risk assessment.
  • Sufficient spoken English so as to be able to comprehend testing procedures. Normative ranges on a C-RENAL blood panel (panel and ranges specified here: https://labguide.fairview.org/showtest.asp?testid=3321)

You may not qualify if:

  • Substance abuse in the participant
  • Neurological condition or other developmental disorder
  • Serious psychiatric disorder known to affect brain functioning and cognitive performance (e.g., schizophrenia, schizoaffective disorder)
  • Medical instability, which will be evident based on required outpatient treatment status. In standard eating disorders treatment, individuals who are not medically stable are referred to higher levels of care (e.g., residential treatment, inpatient). Therefore, if a participant is enrolled in higher level care for their eating disorder diagnosis, this indicates medical instability and they will be excluded from enrollment in this study.
  • tDCS contraindication (e.g., history of craniotomy, history of metallic cranial plates, screws, implanted devices).
  • Acute suicidality (suicidalideation with a plan or intent), assessed via MINI suicidality module and Beck Depression Inventory suicide item
  • Acute homicidality (homicidal ideation with a plan or intent), assessed via MINI
  • Moderate, severe or extreme AN diagnostic severity, based on BMI as per DSM-5 criteria (e.g., BMI \<17.0 kg/m2)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55414, United States

RECRUITING

MeSH Terms

Conditions

Anorexia NervosaFeeding and Eating Disorders

Condition Hierarchy (Ancestors)

Mental DisordersSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Lisa Anderson

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
triple blind
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Pilot mechanistic trial examining cognitive training and brain stimulation effects on cognitive performance. Participants are randomly assigned to active or sham (fake) brain stimulation conditions.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2024

First Posted

October 2, 2024

Study Start

August 2, 2024

Primary Completion (Estimated)

June 2, 2026

Study Completion (Estimated)

June 2, 2026

Last Updated

August 29, 2025

Record last verified: 2025-08

Locations